Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NRSInsights’ December and Full Year 2024 Retail Same-Store Sales Report
-
New “State of the Data Lakehouse in the AI Era” Report Shows Data Lakehouses Accelerating AI Readiness for 85% of Firms
-
Ori Biotech Expands Team to Advance IRO Commercialization and Industry Partnerships
-
Hydreight Technologies Provides Shareholder Update on 2024 Milestones and 2025 Vision
-
Lewis & Ellis Strengthens Leadership in Life & Health and Achieves Significant Growth in Property & Casualty Rankings
-
Abcourt Starts Drilling Campaign on its Flordin Property
-
Subsea7 awarded contract offshore Norway
-
Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers
-
Pongo: The XRP Trench Warrior Accelerates XRPL Adoption with MEXC Listing
-
Kvika banki hf.: Announcement from Kvika's Nomination Committee regarding candidacy for the Board of Directors
-
Russell Square Completes Phase 1 of The Highlands at Silverdale, Delivering 234 Units
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
AI Unlimited Group Unveils 2025 Vision for Integrated AI-Powered Ecosystem
-
Uniti Group Inc. Announces Launch of Fiber Securitization Notes Offering
-
IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma
-
Loenbro Acquires Revolution Industrial, Expanding Regional Service Capabilities
-
Allegro MicroSystems to Announce Third Quarter Fiscal 2025 Financial Results
-
Matt McNally returns to Publicis Groupe to spearhead its global health transformation practice
-
WALKER RIVER ANNOUNCES SIGNIFICANT GOLD INTERCEPTS INCLUDING 3.88 G/T OVER 77.72 METERS AT THE LAPON GOLD PROJECT
-
agentOS Proptech Group Joins Volaris Group to Support Long-Term Growth in Property Management Vertical
-
Daré Bioscience to Participate in the Women’s Health Series at the 43rd Annual J.P. Morgan Healthcare Conference
-
Boehringer Ingelheim Acquires Fourth License for the Development of Novel Antibody Based Cancer Treatments from Oxford BioTherapeutics
-
WillScot Announces 2025 Investor Day & Reaffirms FY2024 Outlook
-
Enphase Energy Expands in Latin America with Launch of IQ8 Microinverters in Colombia, Panama, and Costa Rica
-
EagleBank Adds New Market Executive and Two Relationship Managers to C&I Lending Team
-
Three-Trade Union Agreement Signed for Grange Solar Grazing Center
-
BCA: Advanced Technologies for Restoring Trust and Reclaiming Lost Assets
-
Frontier Medicines Announces FMC-220, the First Covalent p53 Y220C Activator Development Candidate, with Best-in-Class Potential
-
Taseko Announces 2024 Production Results
-
Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction
-
Fujifilm Celebrates 8 New Recipients of Fujifilm Fellowships at Harvard Medical School
-
WillScot Announces 2025 Investor Day & Reaffirms FY2024 Outlook
-
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
-
Esperion to Host Virtual Key Opinion Leader Event on Wednesday, January 22, 2025, at 11:30 a.m. ET.
-
New England Life Care Selects Inovalon’s ScriptMed® to Scale Infusion Therapy and Specialty Pharmacy
-
NEWSMAX HOSTS EXCLUSIVE INAUGURATION EVE CELEBRATION AT THE ANDREW W. MELLON AUDITORIUM
-
Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of the Company’s Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findin
-
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Freshworks to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
-
Nyrstar NV – Postponed assessment of request for appointment of provisional administrator
-
Boehringer Ingelheim Acquires Fourth License for the Development of Novel Antibody Based Cancer Treatments from Oxford BioTherapeutics
-
Taseko Announces 2024 Production Results and Amendment to Gibraltar Silver Stream
-
Net Asset Value(s)
-
Constellation Brands Declares Quarterly Dividend
-
ElevateBio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Novacium Partners with the French Army's Technical Section to Develop High-Capacity Silicon-Based Batteries
-
Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
GURU Organic Energy to Report Fourth Quarter and Fiscal Year 2024 Results
-
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
-
Eterna Therapeutics Announces Appointment of Dr. Elena Ratner to Board of Directors
